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ABSTRACT
￿
Thrombospondin (TS), a protein first described in platelets, was recently shown to
be synthesized and secreted by endothelial cells, fibroblasts, and smooth muscle cells. The
presence of TS in the extracellular matrix of cultured cells has prompted us to examine the
associations of this protein with matrix macromolecules. Interactions of TS with both matrix
and serum proteins were tested using an enzyme-linked immunosorbent assay. With this assay
we assessed the binding of TS in solution to proteins adsorbed to polystyrene microtiter plates.
Among collagens, platelet TS bound to type V but not to types I, III, or IV. This selective
interaction was confirmed in experiments using proteins linked to cyanogen bromide-activated
Sepharose. TS released from platelets in response to thrombin activation, as well as that
secreted by endothelial cells in culture, bound to type V but not to type I collagen-Sepharose.
No binding was observed to denatured type V collagen-Sepharose. The binding region for
type V collagen was located in a chymotrypsin-produced fragment of TS with chains of M, =
70,000, after reduction. Interactions of TS with a number of other proteins, including fibro-
nectin, fibrinogen, and laminin, could be demonstrated using the enzyme-linked immunosor-
bent assay technique but the interpretation of these findings is difficult since comparable
binding to protein-Sepharose was not always observed. Our findings suggest that both the
extravascular distribution and function of TS in vivo may involve an interaction with type V
Collagen.
Thrombospondin (TS)' is a glycoprotein consisting of three,
possibly identical, disulfide-bonded chains of - 140,000 mol
wt (25, 31). The protein was initially described in platelets
and was shown to be released from storage in a-granules by
the action of thrombin (2, 18). A fraction of the secreted TS
binds to the platelet surface (15, 39). Subsequently TS, or a
protein very similar to it, was shown to be secreted by endo-
thelial cells (9, 34, 36, 42, 45) and by various other cells in
culture, including fibroblasts (21, 40), smooth muscle cells
(40), and granular pneumocytes (43). The observation by
immunofluorescence of TS in a fibrillar extracellular mesh-
work in cultured cells (21, 40) suggested that TS may function
as a normal component of the extracellular matrix in vivo.
It has been proposed that TS acts as an endogenous lectin
in platelet aggregation by binding to fibrinogen associated
'Abbreviations used in this paper: ELISA, enzyme-linked immuno-
sorbent assay; TS, thrombospondin.
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with the activated platelet surface (20). Support for this pro-
posal has come from the observation that fibrinogen in solu-
tion can form a complex with TS adsorbed to a plastic surface
(26). In addition, Lahav et al. (22) have provided evidence for
the interaction ofTS with fibronectin during platelet adhesion
and aggregation. Using a radioactive cross-linking agent, an
interaction was observed between TS released from activated
plateletsand fibronectin or collagen adsorbed to a glasssurface
(22).
In view of the synthesis of TS by a variety of cells and its
location in the extracellular milieu, we thought it likely that
its function in the extracellular matrix would involve inter-
actions with matrix proteins. We therefore tested the interac-
tion ofTS with various purified extracellular matrix proteins,
as well as with representative serum and intracellularproteins,
by an enzyme-linked immunosorbent assay (ELISA) method.
Further testing of positive interactions was performed by
examination of the binding of "'I-TS to proteins coupled to
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V collagen; this finding may provide a clue to the location
and function of TS in the extracellular matrix.
MATERIALS AND METHODS
Preparation and Modification of Thrombospondin:
￿
TS was
isolated from human platelets by the method of Lawler and Slayter (24) as
modified by Raugi et al. (40), with the following changes. In some experiments
the EDTA in the platelet suspension buffer was replaced with I mM CaC12.
Activation ofplateletswasaccomplished by adding human thrombin (obtained
from W. Kisiel, University of Washington) to a final concentration of 0.7
National Institutes of Health U/ml and the thrombin was inactivated by
addition of phenylmethylsulfonyl fluoride to a final concentration of 2 mM.
When calcium was present in the platelet suspension buffer, the platelets
aggregated promptly after addition of thrombin. The platelet aggregate was
rapidly removed by centrifugation at 900g for 2 min at 4°C (J. Lawler, personal
communication). The supernate was snap frozen and rewarmed at 37C.
Residual insoluble material was removed by centrifugation at 27,000 g for 20
min at 4°C (49). The protease inhibitor N-ethylmaleimide was added to the
supernatant fraction to a final concentration of 1 .25 mg/ml. The releasate was
then applied to a Sepharose CL-4B column (2.5 x 100 cm), equilibrated in a
buffer containing 20 mM Tris-HCI, 150 mM NaCl, and either 2.5 mM EDTA
or 1.0 mM CaC12, pH 7.5. The eluate was monitored by absorbance at 280 nm
and fractions containing TS were pooled and passed over a column containing
5 ml ofheparin-Sepharose 6B (Pharmacia, Inc., Piscataway, NJ). The column
was washed with 20 mM phosphate buffer, pH 7,5, containing 150 mM NaCl,
and either 25 AM EDTA or 50 MM CaC12. A further wash with the same buffer
containing 300 mM NaCl was performed, before elution of TS with 20 mM
phosphate buffercontaining 600 mM NaCl and either 25,uM EDTA or 50 ,UM
CaC12. Yields of up to 6 mg of TS were obtained from 4 U platelets, with a
peak concentration of eluate from the heparin-Sepharose column of -2 mg/
ml. Bovine platelet TS was prepared by a previously published method (40).
TS was iodinated with the Iodo-Gen reagent (1,3,4,6-tetrachloro-3a, 6a-
diphenylglycouril ; Pierce Chemical Co., Rockford, IL) using the method of
Salacinski et al. (48). "I-TS was separated from free iodine by gel filtration on
a column of G-25 (medium) Sephadex (Pharmacia, Inc.) equilibrated in PBS.
Specific activities of 700-2,400 dpm/ng were obtained. After chromatography,
BSA was added as a carrier to a final concentration of 1 mg/ml and the TS
diluted (if necessary) to a maximum concentration of 100 mg/ml. Analysis
showed >95% of the radioactivity to be precipitable in 10% trichloroacetic
acid. SDS PAGE followed by autoradiography showed no discernible degrada-
tion from the iodination since all ofthe radioactivity was present in TS and in
a small amount of a lower molecularweight derivative in the starting material.
Chymotryptic fragments of TS were prepared as described by Raugi et al.
(Raugi, G. J., S. M. Mumby, and P. Bornstein, manuscript in preparation).
Briefly, TS prepared in the presence of calcium was digested with a-chymo-
trypsin (three times crystallized, Worthington Diagnostics, Freehold, NJ) for
30 min at 37°C with an enzyme/substrate ratio of 1 :200 (wt/wt). The reaction
was terminated by adding diisopropylfluorophosphate (Aldrich Chemical Co.,
Milwaukee, WI) to a final concentration of 2 mM. Solutions of chymotryptic
fragments were diluted fourfold to reduce the NaCl concentration to 150 mM
before use for analysis of binding to ligand-Sepharose samples.
Other Proteins:
￿
Fibronectin was purified by gelatin-Sepharose chro-
matography of cryoprecipitated human plasma (10). BSA and human and
sheep IgG were purchased from Miles Laboratories, Inc. (Elkhart, IN). Grade
V chicken ovalbumin was purchased from Sigma Chemical Co. (St. Louis,
MO). Bovine fibrinogen and human von Willebrand factor were provided by
M. Chopek, University ofWashington. Human coagulation factors IX, and X,
were provided by W. Kisiel, University of Washington. Human plasma low
density and high density lipoproteins were provided by J. Oram, University of
Washington. Rabbit skeletal muscle phosphorylase b was obtained from E. H.
Fischer, University of Washington. Catatase was purchased from Pharmacia
Fine Chemicals (Div. of Pharmacia, Inc.). Lathyritic rat skin collagen (type I)
was prepared as described by Bornstein and Piez (4). Human collagen types I,
III, and IV were provided by Helene Sage, University of Washington. Human
fetalmembrane andbovine uterustypeV collagens were obtained from Dietrich
Horlein, Bio-Gen, Geneva, and Beat Trueb, University of Washington, respec-
tively. A characterization of one of these preparations and other similarly
prepared type V collagens has been reported (44)., Denatured collagens were
prepared by heating native collagen solutions at 55°C for 30 min.
Laminin was provided by A. Oohira (University of Washington) and had
been fractionated from the culture medium of ['Hlproline-labeled PYS-2 cells
by ammonium sulfate precipitation (37). The precipitate was dissolved in PBS
containing 3 M urea and protease inhibitors (0.2 mM phenylmethanesulfonyl
fluoride, 10 mM N-ethylmaleimide, and 2.5 mM EDTA). The proteins were
resolved by DEAF cellulose (DE52, Whatman Laboratory Products, Inc.) (1)
and hydroxylapatite (Bio-Rad Laboratories, Richmond, CA) chromatography
(34). Laminin purity was established both by Coomassie Blue staining and by
fluorography of SDS polyacrylamide gels (37). Protein concentrations were
determined by the method of Bradford (5) or Lowry et al. (28) using bovine
pancreas a-chymotrypsin as a standard (Worthington Diagnostics).
ELISA:
￿
TS binding to proteins adsorbed to polystyrene was assayed by
ELISA. Wells of Immulon l 96-well microtiter plates (Dynatech Laboratories,
Alexandria, VA) were coated with 50 pl ofproteins in solution at 5 ug/ml (in
PBS; in some cases collagens were in 25 mM acetic acid). The microtiterplate
was rinsed with 0.15 M NaCl in 0.05% Tween-20 before addition ofTS. 50,uI
of platelet TS at 5 mg/ml in a buffer containing 150 mM NaCl, 1.5 mM
KH2P04, 10.8 mM Na2HP04, 2.7 mM KCI, 0.05% Tween-20, 0.02% NaN3,
and 1 mg/ml BSA (ELISA buffer) was incubated in the protein-coated wells
for I h at 37°C. The plate was rinsed as before and 50 j1 ofrabbit anti-human
platelet TS diluted 1:200 in ELISA buffer was incubated for 1 h at 37°C. The
rabbit immunoglobuhns had been enriched by repeated ammonium sulfate
precipitation and antifibronectin activity had been removed by affinity chro-
matography on fbronectin-Sepharose (40). The microtiter plate was rinsed as
beforeandincubated for 1 h at 37°C with alkaline phosphatase-conjugated goat
anti-rabbit IgG (50 jul of 1:1,000 dilution). The plate was rinsed and then
incubated with 50 kl ofp-nitrophenyl phosphate (1 mg/ml in l M diethanola-
mine, pH 9.8). The plate was incubated at room temperature until the most
positively reacting wells reached an absorbance of 1 .0-1 .2 at 405 nm, as
determined by a Dynatech microtiter plate autoreader (model MR580, Dyna-
tech Laboratories). The data are reported after subtraction of a blank in which
TS was omitted. With. the exception of the assays for von Willebrand factor,
the absorbance for the blanks were all very low (<10%) and did not vary
significantly depending on the protein adsorbed to the plastic. The von Wille-
brand factor blank was <20% ofthe experimental value.
Binding of TS to Proteins Coupled to Sepharose:
￿
Proteins
were coupled to cyanogen bromide-activated Sepharose (Pharmacia, Inc.) at
4°C followingdirections provided by the manufacturer. Briefly, proteins(2 mg/
ml or 5 mg/ml) were solubilized into coupling buffer(0.1 M sodium bicarbon-
ate, pH 8.3, containing 0.5 M NaCI). A protein solution twice the volume of
thegel was rocked end-over-end overnight. The remainingreactivegroupswere
blocked by mixing the gel with 0.2 M glycine, pH 8.0, overnight. Control gels
were mixed first with bicarbonate buffer lacking protein and then with glycine
buffer. The gels were rinsed extensively with the bicarbonate coupling buffer
alternated with 0.1 M acetate buffer, pH 4, containing 0.5 M NaCl. The
efficiency of coupling for native collagen types I and V and phosphorylase b
was -50%. The efficiency of coupling for denatured collagens was 85%.
Fibrinogen, catalase, and fibronectin were coupled at >90% efficiency. The
degree ofcoupling was determined by measuring protein concentration (28) of
the coupling solution before and afterthe cross-linking reaction,
TS bindingto ligand-Sepharose samples was assayed essentially as described
by Lahav et al. (22). To a 0.1-ml sample ofpacked protein-coupled Sepharose
was added either (a) 0.02 ml culture medium conditioned by endothelial cells;
(b) 0.1 ml human platelet releasate (40); (c) 0.1 ml human platelet '2'I-TS at
10 kg/ml; (d) 0.25 ml purified human platelet TS (125 Ag/ml); or (e) 0.25 ml
of a chymotryptic digest ofhuman platelet TS at ^-250 jAg/ml. The solutions
were allowed to incubate with the Sepharose samples at room temperature for
15 min, with brief vortexing every 5 min. The bound and unbound fractions
were then analyzed by SDS PAGE. Those ligand-Sepharose samples used for
'251-TS binding were first rinsed with PBS containing I mg/ml BSA. After
incubation with '251-TS, small equal aliquots of the bound and unbound
fractions were analyzed by counting in a gamma counter (Beckman Instru-
ments, Fullerton, CA, Gamma 4000) as well as by SDS PAGE.
Cell Culture:
￿
PYS-2 cells, from a mouse teratocarcinoma-derived cell
line, were provided by J. Lehman, University of Colorado (Denver, CO). The
cells were cultured and radiolabeled with ['HJproline as described by Oohira et
al. (37) for the isolation oflaminin.
Bovine aortic endothelial cells were provided by S. Schwartz, University of
Washington. The cells were grown in Dulbecco's modified Eagle's medium
(Gibco Laboratories, Grand Island, NY), supplemented with 10% fetal calf
serum, penicillin (100 U/ml), streptomycin (50 kg/ml), and butyl p-hydroxy-
benzoate (0.4 mg/ml). Nearly confluent cultures were labeled overnight with 50
rpCi/ml L-["Slmethionine (1,244.5 Ci/mmol, New England Nuclear, Boston,
MA) in medium containing methionine at only 10% ofthe normal level, and
supplemented with I mg/ml BSA.
RESULTS
A number of proteins were tested for theirability to bind TS,
as detected by a'specific antiserum to TS in an ELISA. The
assay has the advantage of using submicrogram quantities of
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64 7proteins and is easy to perform in an automated manner. The
results of a large number of experiments that tested for the
ability of TS to bind to proteins adsorbed to polystyrene are
summarized in Table I. Similar results were obtained with
human and bovine platelet TS. Purification of TS in the
presence ofCa" is believed to preserve a more native structure
of the protein (23). However, no differences were observed
between the binding of human platelet TS purified in the
presence ofeither 50 g.M Caz+ or EDTA (unpublished exper-
iments).
A striking selective binding of TS to type V collagen was
observed (Table I). However, no interaction between TS and
types I, III, and IV collagens could be demonstrated. This
distinction was not due to the lack of binding of the latter
collagens to plastic since their presence was readily demon-
strated by an ELISA using the appropriate specific antisera
(data not shown). Collagens at 5 Ag/ml, in PBS or 25 mM
acetic acid, exhibited the same selective binding ofTS to type
V collagen. TS was also bound to heat-denatured type V
collagen-coated wells. Prior digestion oftype V collagen with
highly purified bacterial collagenase abolished the binding of
TS (data not shown).
TS also bound to the basement membrane protein, laminin.
Among serum proteins, TS bound to fibronectin, fibrinogen,
von Willebrand factor, factors IX, and Xa and low density
lipoprotein. TS did not bind to albumin, high density lipo-
protein or IgG (Table I). The interaction with fibrinogen
agrees with the finding reported by Leung and Nachman (26).
In some instances quantitative differences in the extent of
binding of TS may be due to differences in the amount of the
protein ligand bound to plastic. However, the distinction
between TS binding to low and high density lipoproteins
TABLE I
Binding of Purified Platelet Thrombospondin to Proteins
Adsorbed to Polystyrene Microtiter Plates
Protein on polystyrene
￿
Thrombospondin binding
None
￿
- (20)
Matrix proteins
Type I collagen, native
￿
-
￿
(25)
denatured
￿
- (2)
Type III collagen, native
￿
-
￿
(3)
Type IV collagen, native
￿
-
￿
(2)
Type V collagen, native
￿
+++ (22)
denatured
￿
+++ (4)
Laminin
￿
++ (2)
Serum proteins
Albumin
￿
- (6)
Plasma fibronectin
￿
+
￿
(9)
Fibrinogen
￿
++ (29)
von Willebrand factor
￿
++
￿
(5)
Factor IX,
￿
+++ (2)
Factor Xa
￿
+++ (2)
Low density lipoprotein
￿
++
￿
(4)
High density lipoprotein
￿
-
￿
(2)
IgG
￿
- (2)
Intracellular proteins
Catalase
￿
+++ (7)
Phosphorylase b
￿
+++ (14)
The results, as assayed by the ELISA method, are reported in relative terms
to summarizethe resultsofmany different experiments performed atdifferent
times. Each experiment included four or more of the proteins listed. No
binding of TS above background is represented by -. Positive binding ofTS
is represented by +, ++, +++. +, 0.1-0.4 absorbance units at 405 nm, ++,
0.4-0.8, +++, 0.8-1 .2. The number of determinations made on different
days for each protein is given in parentheses. Each determination was made
in duplicate or triplicate.
648
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 98, 1984
cannot be attributed to lack of binding of the latter to plastic
since specific antibodies were used in an ELISA to demon-
strate adsorption ofeach lipoprotein (data not shown).
In view of the large number of positive interactions ob-
served for TS with other proteins, we tested two cytoplasmic
proteins, catalase and phosphorylase b, which we had expected
to serve as negative controls. However, both ofthese proteins
bound TS as extensively as did type V collagen (Table I).
Some indication of the nature of the interaction of TS with
proteins was obtained by altering the composition of the
ELISA buffer. The effects ofa higher concentration ofTween-
20, high ionic strength, urea, and SDS on the binding of TS
to several proteins are shown in Fig. 1 . An increase in the
concentration of Tween-20 to I%, from the normal level of
0.05%, had no effect on TS binding (the extent ofbinding in
lanes 1, Fig. 1, were the same at both detergent concentra-
tions). 1 M NaCl nearly abolished binding to type V collagen
but had little effect on the binding of TS to fibrinogen or
phosphorylase b. 4 M urea reduced binding to all three
proteins but, again, the effect was most substantial for type V
collagen. Finally, 0.1 % SDS reduced the binding of TS to all
the proteins tested. These findings suggest that the nature of
the association of TS with type V collagen differs in its
properties from the binding to fibrinogen or phosphorylase b.
To investigate further the specificity of binding, interactions
of TS with proteins linked to Sepharose were tested (Table
II). Iodinated TS was not bound significantly above back-
ground to either native or denatured type I collagen or dena-
tured type V collagen. In contrast, highly significant binding
to native type V collagen-Sepharose was observed. This bind-
ing was as extensive as that to heparin. Human platelet "'I-
TS bound equally well to type V collagen isolated from either
human or bovine tissues (data not shown). Binding of TS to
fibrinogen was modest but significant, and no binding to
fibronectin above control levels was detected (Table II). It was
of considerable interest that neither catalase nor phosphoryl-
ase b could bind TS significantly when these proteins were
linked to Sepharose.
The selective binding of TS to type V collagen was dem-
onstrated by incubating the complex mixture of proteins
secreted by thrombin-activated platelets with type V collagen-
Sepharose. In addition, control Sepharose, type I collagen-
1.2
E I.0
a 0.8
v
0 o.s 0
B
a 0.4
0.2
F_1-_~ ~
1 2 3 4
￿
1 2 3 4
￿
1 2 3 4
￿
1 2 3 4
Fibrinogen
￿
Phosphorylose b
￿
Type V collogen
￿
Type I collogen
FIGURE 1
￿
Effects of detergents, high ionic strength, and urea on
the binding of thrombospondin to proteins adsorbed to polystyrene
plates. Binding in the presence of 1%Tween-20 (lanes 1), 1 M NaCl
(lanes 2), 4M urea (lanes 3) and 0.1%SDS (lanes 4) wasdetermined
by the ELISA method. The levels of binding in 1% Tween-20 (lanes
1) did not differ significantly from those found in the usual concen-
tration of Tween-20, 0.05%.Iodinated platelet TS (1 lag, specific activity 700-2,400 dpm/ng, in PBS
containing 1 mg/ml of BSA) was incubated for 15 min at 20°C with 100 JAI
of ligand-Sepharose beads. Beads were washed three times with PBS
containing BSA, transferred to a clean tube with PBS, and boiled 3 min in
SDS PAGE sample buffer to remove bound radioactivity. Results are ex-
pressed as counts per minute bound/counts per minute bound + counts
per minute unbound . Values represent mean t standard deviation . Values
in parentheses indicate number of measurements .
Value different from control: p < 0.01 .
and heparin-Sepharose were used . The results, as analyzed by
SDS PAGE, are shown in Fig. 2 . Of the mixture of proteins
released by platelets onlyTS was bound to a significant extent
by type V-collagen Sepharose . TS, as well as other proteins,
were bound to heparin-Sepharose whereas no platelet proteins
werebound to type I collagen-Sepharose or control Sepharose .
In the case of both type I and type V collagen-Sepharose, the
hot SDS PAGE sample buffer used to elute proteins from the
ligand-Sepharose also dissociated a fraction of type I and type
V collagen, respectively (Fig. 2B, lanes 2 and 3) . It should be
noted that less of the TS in the platelet releasate bound to
type V collagen than to heparin-Sepharose (Fig . 2) whereas
iodinated TS bound equally well to the two ligands (Table 11) .
It is possible that other proteins in the platelet releasate may
have interfered with the ability of TS to bind to the type V
collagen-Sepharose .
The selectivity of binding of TS to type V collagen was
shown in yet another way by testing for the ability of type V
collagen-Sepharose to bind TS secreted by endothelial cells
into the culture medium. For comparison, control, ovalbu-
min, and type I collagen-derivatized Sepharose samples were
used. Conditioned culture medium from endothelial cells
labeled with [35S]methionine was run over a denatured type I
collagen-Sepharose column to remove fibronectin . The pre-
treatedmedium was incubated with the derivatized Sepharose
samples and the interactions were analyzed by SDS PAGE
and autoradiography. Binding ofTS was detectable for type
V collagen-Sepharose only (Fig. 3). Bands representing other
proteins bound to type V collagen-Sepharose were also ob-
served (lane 4, Fig. 3B) . These proteins may be involved in
the interaction of endothelial cell TS with type V collagen .
However, a requirement for either of the two proteins is
unlikely since purified platelet TS binds to type V collagen in
the absence of any other proteins. Densitometric scanning of
lanes 4 in Fig. 3,A and B indicated that 69% ofthe recovered
TS in the conditioned medium was bound to type V collagen .
If the culture medium had not been pretreated to remove
fibronectin, <20% of the TS bound to type V collagen-
Sepharose (data not shown) . The total TS in the unbound
and bound fractions from type V collagen-Sepharose (lanes
4, Fig. 3) do not equal that in the starting material (lane 1,
Fig . 3 A) . It is likely that some of the TS originally bound to
type V collagen was lost during the washing ofthe Sepharose
to remove nonspecifically-bound proteins.
In an attempt to locate the type V collagen-binding region
FIGURE 2 Binding of secreted platelet proteins to Sepharose-
bound ligands . Proteins secreted by thrombin-activated platelets
were incubated with samples of ligand-Sepharose and equal por-
tions of the unbound and bound proteins were analyzed by SDS
PAGE (6 and 10% composite gel) in the presence of dithiothreitol
and Coomassie Blue staining. (A) Unbound platelet proteins ; (B)
proteins bound to ligand-Sepharose samples . Lanes 1, control Seph-
arose ; lanes 2, type I collagen-Sepharose ; lanes 3, type V collagen-
Sepharose ; lanes 4, heparin-Sepharose . Arrows indicate the posi-
tions of migration of thrombospondin (TS), type V collagen a-chains
[al(V), a2(V)], and type I collagen a-chains [a](1), a2(l)] . Collagen
chains were dissociated from the collagen-Sepharose samples by
the hot SDS PAGE sample buffer used to elute bound proteins.
FIGURE 3 Ligand-Sepharose binding of endothelial cell secreted
proteins after removal of fibronectin . Endothelial cell proteins were
metabolically labeled with ['1S]methionine in the presence of 1 mg/
ml BSA and were then passed over a denatured type I collagen-
Sepharose column to remove fibronectin . Equal portions of condi-
tioned medium proteins were then assayed with various ligand-
Sepharose preparations . Unbound (A) and bound (B) samples were
analyzed by SIDS PAGE (6 and 10% composite gel) in the presence
of dithiothreitol, and autoradiography . Lanes 1, control-Sepharose ;
lanes 2, ovalbumin-Sepharose; lanes 3, type I collagen-Sepharose;
lanes 4, type V collagen-Sepharose . The arrow indicates the position
of migration of thrombospondin (TS).
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Binding of "'I-TS
Ligand
TABLE II
to Sepharose-coupled ligands
[' zs l]TS-bound
Control 6 ± 2 (5)
Native type I collagen 6 ± 2 (6)
Denatured type I collagen 6 ± 2 (3)
Native type V collagen 65 ± 5 (8)*
Denatured type V collagen 6 ± 3 (3)
Fibrinogen 13 ± 2 (4)`
Plasma fibronectin 5 ± 1 (4)
Heparin 50 ± 13 (7)'
Catalase 10 ± 7 (4)
Phosphorylase b 6 ± 2 (4)FIGURE 4
￿
Binding of thrombospondin and its chymotryptic frag-
ments to type V collagen-Sepharose . Unbound (A) and bound (B)
fractions were resolved by SDS PAGE (4-20% gradient gel) in the
presence of dithiothreitol and visualized by Coomassie Blue stain-
ing. Lanes 1, TS and control Sepharose ; lanes 2, TS and type V
collagen-Sepharose ; lanes 3, chymotryptic fragments and control
Sepharese; lanes 4, chymotryptic fragments and type V collagen-
Sepharose . 12.5% of the unbound fractions and 24% of the bound
fractions were loaded on the gel . The arrows indicate the positions
of migration of thrombospondin (TS), the 70,000-mol-wt fragment
(70), the 28,000-mol-wt fragment (28), and type V collagen a-chains
[a 1(V), a2(V)I .
in TS, the protein was cleaved with chymotrypsin under
conditions that lead to the production oftwo stable fragments
with chain molecular weights of 70,000 and 28,000 after
reduction (Raugi, G . J ., S . M . Mumby, and P . Bornstein,
manuscript in preparation) . The chain M, = 28,000-fragment
binds to heparin (Raugi,G. J ., S . M . Mumby, and P. Born-
stein, manuscript in preparation) and is presumably similar
to the chain M, = 30,000 heparin-binding fragment of TS
described by others (8, 24) . As shown in Fig. 4, purified TS
bound almost quantitatively to type V collagen-Sepharose
(lanes 2) but not to control Sepharose (lanes 1). When a
chymotryptic digest ofTS was incubated with typeV collagen-
Sepharose, selective binding ofthe larger fragment, composed
ofM, = 70,000 chains, was observed ; essentially no binding
of the heparin-binding fragment occurred (lanes 4) . Control
Sepharose bound neither of the fragments (lanes 3) . These
experiments provide preliminary evidence for a domain struc-
ture with multiple binding sites for TS, analogous to that
described for fibronectin (19) .
DISCUSSION
The identification ofTS in the extracellular matrix ofcultured
cells (21, 40) has led us to examine whether specific interac-
tions with matrix macromolecules could be demonstrated .
Such interactions might provide information regarding the
distribution and function of TS in vivo. We initially chose
the ELISA method to detect protein interactions because of
its economy in u, .-- of protein, ease, and speed. A striking
selectivity for binding of type V collagen, to the exclusion of
types 1, III, and IV, was observed (Table I) . However, a
perplexing number of positive reactions with other proteins
was observed . In the cases of fibrinogen and fibronectin,
interactions with TS had been reported under different exper-
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imental conditions (22, 26) ; however, with cytoplasmic pro-
teins such as catalase and phosphorylase b, an association was
not expected .
It seemed possible that the adsorption of proteins to a
plastic surface might permit anomalous interactions. We at-
tempted to inhibit such possibly adventitious interactions,
unsuccessfully, by increasing the concentration of detergent
during the TS binding phase of the ELISA assay (Fig . 1) .
Indeed, the interaction ofphosphorylase b withTS withstood
high ionic strength whereas that of type V collagen did not
(Fig. 1) . We therefore assessed the ability of a number of
different proteins, coupled in solution to Sepharose, to bind
TS . Selective binding of "I-TS to type V collagen was main-
tained under these conditions (Table II) . Some indication of
specificity was provided by the finding that binding was
abolished when type V collagen was heat denatured prior to
linkage to Sepharose . It therefore appears that the native
structure of the triple helix is required for the complex for-
mation betweenTS and type V collagen coupled to Sepharose .
Additional support for the interaction of TS and type V
collagen came from the demonstration that TS could be
selectively bound to type V collagen-Sepharose from a com-
plex mixture of proteins present in the supernatant fraction
of thrombin-activated platelets (Fig . 2) or in the conditioned
medium of endothelial cells . In the latter case more extensive
binding could be shown when fibronectin was removed prior
to the interaction (Fig. 3) . Increased interaction of TS with
type V collagen caused by removal of fibronectin could be
indicative of TS and fibronectin binding to the same site on
the collagen molecule .
No interaction ofplatelet 12'I-TS or endothelial cell TS with
catalase- or phosphorylase-Sepharose was observed (Table II
and unpublished observations), although platelet TS did bind
to the enzymes when they were adsorbed to plastic (Table I) .
The interaction of TS with the cytosolic enzymes was not
expected and may not be physiologically relevant . We have
also detected binding of fibrinogen, von Willebrand factor,
and type V collagen to phosphorylase b adsorbed to plastic .
Adsorption of the enzymes to plastic may cause a conforma-
tional change resulting in the exposure of nonspecific protein
binding sites . It has been demonstrated that adsorption of
fibronectin to hydrophobic polystyrene causes conforma-
tional changes in the fibronectin molecule as determined by
assay ofbiological activity and reactivity with antifibronectin
(16, 17) . These findings, together with a recently published
study ofthe binding of proteoglycan link protein to collagens
(6), indicate that the ELISA technique may be useful as a
screening procedure but that positive interactions should be
confirmed by another binding assay.
The structural basis for the selective binding ofTS to type
V collagen, as opposed to other closely related collagens such
as types I or III, is not known. However, type V collagen
differs from other interstitial collagens in posessing (a) a
markedly reduced susceptibility to vertebrate collagenase (44),
(b) a higher proportion of larger hydrophobic amino acids
(35), and (c) different fibril-forming capability (7) . If a limited
TS-binding domain can be defined in type V collagen, its
structure would be of interest. An analysis of the binding of
TS to type V procollagen, secreted by A204 rhabdomyosar-
coma cells (1), would also be informative.
We have preliminary evidence that the region of TS re-
sponsible for binding to type V collagen differs in location
from the heparin-binding site . As shown in Fig . 4, a largechymotryptic fragment ofTS with chains ofMr = 70,000 after
reduction bound to type V collagen, whereas the smaller
chymotryptic fragment did not. The M r = 28,000 chymotryp-
tic fragment binds to heparin (Raugi, G. J., S. M. Mumby,
and P. Bornstein, manuscript in preparation) and is presum-
ably similar to the heparin-binding fragment generated by
thrombin, plasmin, trypsin, or thermolysin (8, 24). These
findings suggest that thrombospondin may be another exam-
ple of a modular protein, such as fibronectin, in which dis-
crete, relatively protease-resistant binding domains are sepa-
rated by more flexible protease-sensitive regions (19, 41).
Gartner et al. (12) have reported that an endogenous lectin,
secreted by activated platelets, binds to fibrinogen on the
platelet surface. It has been suggested by Jaffe et al. (20) that
TS functions as such a lectin. In their view platelets interact
with each other by intercellular bridges of multivalent TS
anchored to fibrinogen. This model is supported by the recent
demonstration that fibrinogen in solution binds to TS ad-
sorbed to a plastic surface (26). In our experience the inverse
reaction, i.e., binding ofTSto adsorbed fibrinogen, also occurs
(Table 1). An interaction between 125I-TS and fibrinogen-
Sepharose could also be demonstrated, although the extent of
the interaction was not as great as that between TS and type
V collagen or heparin (Table II).
The interactions between TS and type V collagen or fibrin-
ogen should be considered in the context of the interactions
with other proteins that have been detected, using the modi-
fied ELISA technique alone. The interaction with von Wille-
brand factor may be physiologically significant in that the
protein is thought to play a role in platelet aggregation and
adhesion, particularly at sites of vascular injury (11, 47). It
should be noted, however, that Leung and Nachman (26)
were unable to demonstrate an interaction of fluid phase von
Willebrand factor with adsorbed TS. The binding of TS to
factors IX. and Xa may be a consequence of the ability of
these serine proteases to cleave TS (Raugi, G. J., S. M.
Mumby, and P. Bornstein, manuscript in preparation). TS
could also play a structural role in association with laminin
in basement membranes. The reason for the binding ofTS to
low density lipoprotein, yet to be confirmed by other means,
is currently not understood. It is, however, interesting that TS
has been shown by immunofluorescence techniques to be
located in some basement membranes and in the thickened
intima of atherosclerotic aorta (Wight, T., G. J. Raugi, S. M.
Mumby, and P. Bornstein, manuscript in preparation), re-
gions in which association with laminin or low density lipo-
protein respectively, would be possible.
A role for TS and fibronectin in platelet adhesion or aggre-
gation has been suggested by -Lahav et al. (22). Using a
radioactive cross-linking agent, these workers showed an in-
teraction of TS on the surface of platelets with fibronectin or
type I collagen adsorbed to glass. Binding of endothelial cell
TS to plasma fibronectin coupled to Sepharose was also
demonstrated. We were unable to observe binding of endo-
thelial cell TS to fibronectin-Sepharose, although fibronectin
in the culture medium of endothelial cells bound to TS-
Sepharose (unpublished data). A moderate interaction of
platelet TS with fibronectin bound to plastic was also shown
by the ELISA method (Table I). Although an interaction
between type I collagen and TS on the platelet surface was
observed by Lahav et al. (22), we did not detect binding of
purified TS to type I collagen adsorbed to plastic (Table I) or
coupled to Sepharose (Figs. 2 and 3). It is possible that other
factors on the platelet surface are required for an interaction
between the two proteins to occur.
The selective binding of TS to type V collagen raises the
possibility that this interaction may provide a clue to the
extravascular location and function of TS. Type V collagen
has been variously described as existing in or adjacent to
basement membranes (3, 29), in the pericellular matrix (13,
14), in the renal interstitium in close apposition to basement
membranes (32), and in the extracellular matrices of dense
connective tissues (27). Since both endothelial and smooth
muscle cells synthesize type V collagen (30, 33, 46) it is also
likely to exist in blood vessels. Parsons et al. (38) have recently
shown that platelets adhere very poorly to type V collagen
bound to plastic. The possibility exists that in vivo adhesion
of platelets to a subendothelial matrix may be promoted by
the presence of TS. The role that TS plays in connective
tissues at a distance from blood vessels will require further
study. We are currently examining the location of TS in
tissues by immunofluorescence techniques in an attempt to
answer such questions.
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Note AddedIn Proof We have preliminary evidence that the ability
ofTS to bind to type V collagen may be enhanced by preparation of
TS in the relatively low (<_50 liM) Ca" concentrations used in these
experiments.
REFERENCES
1. Ahtalo, K., R. Myllyla,H. Sage, P.Pritzl,A. Vaheri,andP. Bornstein. 1982. Biosynthesis
of type V procollagen by A204, a human rhabdomyosarcoma cell line. J. Biol. Chem.
257:9016-9024.
2. Baenziger, N. L., G. N. Brodie, and P. W. Majerus. 1972. Isolation and properties ofa
thrombin-sensitive protein ofhuman platelets. J. Biol. Chem. 247:2723-2731.
3. Biempica, L., R. Morecki, C. H. Wu, M.A. Giambrone, and M. Rojkind. 1980.
Immunocytochemical localization oftype B collagen. A component ofbasement mem-
branein human liver.Am. J. Path. 98:591-602.
4. Bornstein, P., and K. A. Piez. 1966. The nature of the intramolecular crosshnks in
collagen: theseparation and characterization ofpeptides from the crossfnkregionofrat
skin collagen. Biochemistry. 5:3460-3473.
5. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.
72:248-254.
6. Chandrasekhar, S., H. K. Kleinman, and J. R. Hassell. 1983. Interaction oflink protein
with collagen. J. Biol. Chem. 258:6226-6231.
7. Chiang, T. M., C. L. Mainardi, J. M. Seyer, and A. H. Kang. 1980. Collagen-platelet
interaction :typeV (A-B) collageninduces plateletaggregation.J. Lab. Clin. Med. 95:99-
107.
8. Dixit, V. M.,G. A.Grant, S. A. Santoro,and W. A. Frazier. 1983. Isolation ofa heparin-
binding domain fromproteolytic digestsofplatelet thrombospondin.Fed. Proc. 42:1993.
9. Doyle, M. J., D. F. Mosher, and E. A. Jaffe. 1980. Endothelial cells synthesize and
secrete thrombospondin. J. CellBiol. 87:306a. (Abstr.)
10. Engvall, E., and E. Ruoslahti. 1977. Binding of a soluble form of fibroblast surface
protein, fibronectin, to collagen. Int. J. Cancer20:1-5.
11. Fauvel, F., M. E.Grant,Y. J. Legrand, H. Souchon, G. Tobelem, D. S. Jackson, andJ.
P. Caen. 1983. Interaction of blood platelets with a microfibrillar extract from adult
bovineaorta: requirement for von Willebrand factor.Proc. Natl. Acad. Sci. USA. 80:551-
554.
12. Gartner, T.. K., J. M. Gerrard, J. G. White, and D. C. Williams. 1981. Fibrinogen is
thereceptorforthe endogenouslectin ofhuman platelets. Nature(Lond.). 289:688-690.
MUMBY ET AL.
￿
Interaction of Thrombospondin with Type VCollagen
￿
65 113. Gay, S., A. Martinez-Hernandez, R. K. Rhodes, and E. J. Miller. 1981. Thecollagenous
exocytoskeleton ofsmooth muscle cells. Collagen RelatedRes. 1 :377-384.
14. Gay, S., R. K. Rhodes, R. E. Gay, and E.J. Miller. 1981. Collagen moleculescomprised
of al(V)-chains (Bchains): an apparent localization in the exocytoskeleton. Collagen
RelatedRes. 1 :53-58.
15. George, J. N., R. M. Lyons, and R. K. Morgan. 1980. Membrane changes associated
withplatelet activation. Exposure ofactin on theplatelet surface after thrombin-induced
secretion. J. Clin. Invest. 66:1-9.
16. Grinnell, F., and M. K. Feld. 1981. Adsorption characteristics ofplasma fibronectin in
relationship to biological activity. J Biomed. Mater. Res. 15:363-381.
17. Grinnell, F., and M. K. Feld. 1982. Fibronectin adsorption on hydrophilic and hydro-
phobic surfaces detected by antibody binding and analyzed during cell adhesion in
serum-containing medium. J Biol. Chem. 257:4888-4893.
18. Hagen, 1. 1975. Effects of thrombin on washed, human platelets: changes in the
subcellular fractions. Biochim. Biophys. Acta. 392:242-254.
19. Hynes, R. O., and K. M. Yamada. 1982. Fibronectins: multifunctional modular glyco-
proteins.J. CellBiol. 95:369-377.
20. Jaffe, E. A., L. L. K. Leung, R. L. Nachman, R. 1. Levin, and D. F. Mosher. 1982.
Thrombospondin isthe endogenouslectin ofhuman platelets. Nature (Lond.). 295:246-
248.
21. Jaffe, E. A., J. T. Ruggiero, L. L. K. Leung, M. J. Doyle, P. J. McKeown-Longo, and
D. F. Mosher. 1983. Cultured human fibroblastssynthesizeandsecretethrombospondin
and incorporate it into extracellular matrix. Proc. Nail. Acad. Sci. USA. 80:998-1002.
22. Lahav, J., M. A. Schwartz, and R. O. Hynes. 1982. Analysis ofplatelet adhesion with a
radioactivechemical crosslinking reagent: interactionofthrombospondin with fibronec-
tin and collagen. Cell. 31 :253-262.
23. Lawler, J., F. C. Chao, and C. M. Cohen. 1982. Evidenc efor calcium-sensitivestructure
in platelet thrombospondin. Isolation and partial characterization ofthrombospondin
in the presence ofcalcium. JBiol. Chem. 257:12257-12265.
24. Lawler, J. W., and H. S. Slayter. 1981. The release of heparin-binding peptides from
platelet thrombospondin by proteolytic action of thrombin, plasmin, and trypsin.
Thromb. Res. 22:267-279.
25. Lawler, J. W., H. S. Slayter, and J. E. Coligan. 1978. Isolation andcharacterization ofa
high molecular weight glycoprotein from human blood platelets. J. Biol. Chem.
253:8609-8616.
26. Leung, L. L. K., and R. L. Nachman. 1982. Complex formation of platelet thrombo-
spondin with fibrinogen. JClin. Invest. 70:542-549.
27. Linsenmayer,T. E.,J. M. Fitch, T. M. Schmid, N. B. Zak, E. Gibney, R. D. Sanderson,
and R. Mayne. 1983. Monoclonal antibodiesagainst chicken type Vcollagen: produc-
tion,specificity,and use for immunocytochemicallocalization inembryonic cornea and
otherorgans. JCellBiol. 96:124-132.
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measure-
ment with the Folin phenol reagent. JBiol. Chem. 193:265-275.
29. Madri, J. A., and H. Furthmayr. 1979. Isolation and tissue localization of type ABr
Collagen from normal lung parenchyma. Am. J. Pathol. 94:323-330.
30. Madri, J. A., B. Dreyer, F. A. Pitlick, and H. Furthmayr. 1980. The collagenous
components ofthe subendothelium. Correlationofstructure and function. Lab. Invest.
43:303-315.
31 . Margossian, S. S., J. W. Lawler, and H. S. Slayter. 1981. Physical characterization of
platelet tbrombospondin. J. Biol. Chem. 256:7495-7500.
652
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 98, 1984
32. Martmez-Hernandez, A., S. Gay, and E. J. Miller. 1982. Ultrastructural localization of
type Vcollagen in rat kidney. JCell Biol. 82:343-349.
33. Mayne, R., M. S. Vail, and E. J. Miller. 1978. Characterization ofthe collagen chains
synthesized byculturedsmooth musclecells derivedfrom rhesus monkey thoracicaorta.
Biochemistry. 17:446-152.
34. McPherson, J., H. Sage, and P. Bornstein. 1981 . Isolation and characterization ofa
glycoproteinsecretedby aorticendothelialcellsin culture: Apparent identity withplatelet
thrombospondin. J Biol. Chem. 256:11330-11336.
35. Miller, E. J., S. Gay, M. A. Haralson, A. Martinez-Hermtndez,and R. K. Rhodes. 1982.
Chemistr yand biology of the type Vcollagen system. In New Trends in Basement
Membrane Research. K. Kuehn, H. Schoene, and R. Timpl, editors. Raven Press, New
York. 99-105.
36. Mosher, D. F., M. J. Doyle, and E. A. Jaffe. 1982. Synthesis and secretion of thrombo-
spondin by cultured human endothelial cells. J. Cell Biol. 93:343-348.
37. Oohira, A., T. N. Wight, J. McPherson, and P. Bornstein. 1982. Biochemical and
ultrastructural studies of proteoheparan sulfates synthesized by PYS2, a basement
membrane-producing cell line. J. CellBiol. 92:357-367.
38. Parsons, T. J., D. L. Haycraft, J. C. Hoak, and H. Sage. 1983. Diminished platelet
adherenceto type VCollagen. Arteriosclerosis. 3:589-598.
39. Phillips, D. R., L. K. Jennings, and H. R. Prasanna. 1980. Ca** mediated association
of glycoprotein G(thrombin-sensitive protein, thrombospondin)with human platelets.
J. Biol. Chem. 255:11629-11632.
40. Raugi, G. J., S. M. Mumby, D. Abbott-Brown, and P. Bornstein. 1982. Thrombospon-
din: synthesisand secretion by cells in culture.J. CellBial 95:351-354.
41. Ruoslahti, E., E. Engvall, and E. G. Hayman. 1981. Fibronectin: Current concepts of
its structure and functions. Collagen Rel. Res. 1 :95-128.
42. Sage, H., E. Crouch, and P. Bornstein. 1979. Collagen synthesis by bovine aortic
endothelial cells in culture. Biochemistry. 18:5433-5442.
43. Sage, H., F. H. Farin, G. E. Striker, and A. B. Fischer. 1983. Granular pneumocytes in
primary culture secrete severalmajor components ofthe extracellularmatrix. Biochem-
istry. 22:2148-2155.
44. Sage, H., P. Pritzl, and P. Bornstein. 1981. Susceptibility of type Vcollagen to neutral
proteases: evidence that the major molecular species is a thrombin-sensitive heteropo-
lymer [al(V)]ra2(V). Biochemistry. 20:3778-3784.
45. Sage, H., P. Pritzl,and P. Bornstein. 1981. Secretory phenotypes ofendothelial cells in
culture: acomparison ofaortic, venous, capillary,and corneal endothelium. Arterioscle-
rosis. 1:427-442.
46. Sage, H., P. Pritzl, and P. Bornstein. 1981 . Characterization ofcell matrix associated
collagens synthesizedby aortic endothelial cells in culture. Biochemistry. 20:436-442.
47. Sakariassen, K. S., P. A. Bolhuis,and J. J. Sixma. 1979. Human blood platelet adhesion
to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to
the subendothelium. Nature (Loud.). 279:636-638.
48. Salacinski, P. R. P., C. McLean, J. E. C. Sykes, V. V. Clement-Jones, and P. J. Lowry.
1981 . Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing
agent, 1,3,4,6-tetrachloro-3a,6a-diphenyl glucouril (lodogen). Anal. Biochem. I t7:136-
146.
49. Young, B. R., M. J. Doyle, W. E. Collins, L. K. Lambrecht, C. A. Jordan, L. K.
Albrecht, D. F. Mosher, and S. L. Cooper. 1982. Effect of thrombospondin and other
platelet a-granule proteins on artificial surface-induced thrombosis. Trans. Am. Soc.
ArtifIntern. Organs. 28:498-503.